Captopril increased mitochondrial coenzyme Q10 level, improved respiratory chain function and energy production in the left ventricle in rabbits with smoke mitochondrial cardiomyopathy

BioFactors

Volumn 10, Issue 1, 1999, Pages 61-65

  Gvozdjáková, Anna ^a   Šimko, Fedor ^a   Kucharská, Jarmila ^a   Braunová, Zuzana ^a   Pšenek, Peter ^a   Kyselovič, Ján ^a  

^a Physics and Informatics   (Slovakia)

Author keywords

Captopril; Coenzyme Q10; Heart; Mitochondria; Passive smoking

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CAPTOPRIL; CYTOCHROME C OXIDASE; UBIDECARENONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; HEART LEFT VENTRICLE; HEART MITOCHONDRION; HEART PROTECTION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PASSIVE SMOKING; PRIORITY JOURNAL; RABBIT; RESPIRATORY CHAIN; RESPIRATORY FUNCTION;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 2042484384     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520100107     Document Type: Article

References (17)

1. M. Bartosz, J. Kedziora and G. Bartosz, Antioxidant and prooxidant properties of captopril and enalapril, Free Radicals in Biology and Medicine 23(5) (1997), 729-735.
2. 10 inessential hypertension, Molecular Aspects of Medicine 15(Suppl.) (1994), s257-s263.
3. S.A. Glanz and W.W. Parmley, Passive smoking and heart disease: mechanisms and risk, Journal of American Medical Association 273(5) (1995), 1047-1053.
4. 10: a new drug for cardiovascular disease, Journal of Clinical Pharmaoology 30 (1990), 596-608.
5. A. Gvozdjáková, V. Bada, L. Sány, J. Kucharská, F. Krutý, P. Božek, L. Tršt'anský and J. Gvozdják, Smoke cardiomyopathy: disturbance of oxidative process in myocardial mitochondria, Cardiovascular Research 18 (1984), 229-232.
6. A. Gvozdjáková, J. Kucharská and J. Gvozdják, Effect of smoking on the oxidative processes of cardiomyocytes, Cardiology 81 (1992), 81-84.
7. 10 on smoke mitochondial cardiomyopathy in rabbits, Cor et Vasa 37(3) (1995), 153-157.
8. A.M. Katz, Angiotensin II: Hemodynamic regulator of growth factor?, Journal of Molecular and Cellular Cardiology 22 (1990), 739-741.
9. S. Kužela, J. Kolarov, V. Krempaský, J. Lakota and V. Ujházy, Mitochondrial ATPase of Zajdela hepatoma, FEBS Letters 91(2) (1978), 222-226.
10. J.K. Lang, K. Gohil and L. Packer, Simulteneous determination of tocopherols, ubiquinols and ubiquinones in blood, plasma, tissue homogenates, and subcellular fractions, Analytical Biochemistry 157 (1986), 106-116.
11. 10 for cardiomyopathy, Klinische Wochenschrift 66 (1988), 583-590.
12. 10 therapy for idiopathic dilated cardiomyopathy, American Journal of Cardiology 654 (1990), 521-523.
13. 10 in clinical cardiology: a long-term study, Molecular Aspects of Medicine 15(Suppl.) (1994), s165-s175.
14. M.A. Pfeffer, ACE inhibition in acute myocardial infarction, New England Journal of Medicine 332 (1995), 118-120.
15. 10 in ischaemic cardiopathy, in: Biomedical and Clinical Aspects of Coenzyme Q, K. Folkers, G.P. Littarru and T. Yamagami, eds, Vol. 6, Elsevier, Amsterdam, New York, Oxford, 1991, pp. 321-326.
16. M. Valkonen and T. Kuusi, Passive smoking induces atherogenic changes in low-density lipoprotein, Circulation 97 (1998), 2012-2016.
17. L.Y. Zang, K. Stone and W.A. Pryor, Detection of free radicals in aqueous extracts of cigarette tar by electron spin resonance, Free Radical in Biology and Medicine 19(2) (1995), 161-167.